EX-23.2 5 tm213908d1_ex23-2.htm EXHIBIT 23.2

 

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-3) and related Prospectus of Assertio Holdings, Inc. for the registration of common stock and preferred stock, various series of debt securities and warrants to purchase any of such securities with a total value of up to $100,000,000 and Prospectus Supplement of Assertio Holdings, Inc for the issuance and sale of up to $25,000,000 of common stock and to the incorporation by reference therein of our report dated March 26, 2020, with respect to the consolidated financial statements of Zyla Life Sciences, Inc., included in its Joint Proxy Statement/Prospectus, filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP

 

Philadelphia, Pennsylvania

January 22, 2021